Persistent outpatient hyperglycemia is independently associated with survival, recurrence and malignant degeneration following surgery for hemispheric low grade gliomas

被引:39
作者
Chaichana, Kaisorn L. [1 ,2 ]
McGirt, Matthew J. [1 ,2 ]
Woodworth, Graeme F. [1 ,2 ]
Datoo, Ghazala [1 ,2 ]
Tamargo, Rafael J. [1 ]
Weingart, John [1 ,3 ]
Olivi, Alessandro [1 ]
Brem, Henry [1 ,3 ]
Quinones-Hinojosa, Alfredo [1 ,2 ]
机构
[1] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD USA
[2] Neurooncol Surg Outcomes Res Lab, Baltimore, MD USA
[3] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA
关键词
Hyperglycemia; low grade gliomas; malignancy; recurrence; survival; CRITICALLY-ILL PATIENTS; PROGNOSTIC-FACTORS; RADIATION-THERAPY; INSULIN THERAPY; CEREBRAL ASTROCYTOMAS; CONTROLLED-TRIALS; RANDOMIZED-TRIAL; ADULT PATIENTS; ONCOLOGY-GROUP; BLOOD-GLUCOSE;
D O I
10.1179/174313209X431101
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Hyperglycemia has been shown to augment tumor growth in vitro. However, the effects of persistent hyperglycemia on survival, recurrence and malignant degeneration in patients undergoing surgery for low grade gliomas remain unknown. Methods: All patients who underwent a craniotomy for hemispheric low grade glioma (WHO grade II) from 1996 to 2006 at a single institution were retrospectively reviewed. Persistent hyperglycemia was defined as serum glucose >180 mu g/dl occurring three or more times between 1 and 3 months post-operatively. The independent association of outpatient glucose levels and recorded clinical and treatment variables with overall survival, tumor recurrence and malignant degeneration was assessed via separate multivariate proportional-hazards regression analyses. Results: In this study, 182 patients (89 fibrillary astrocytomas, 82 oligodendrogliomas and 11 mixed gliomas) were available for analysis. Eighteen (10%) patients experienced persistent hyperglycemia. Patients experiencing persistent hyperglycemia were older (44 +/- 16 versus 34 +/- 15) and more frequently diabetic [3 (17%) versus 4 (2%)]. All other clinical and treatment variables were not significantly different between the two cohorts. After adjusting for inter-group differences including age and diabetes and variables associated with survival and recurrence, persistent hyperglycemia was independently associated with decreased survival (p=0.001), increased recurrence (p=0.0001) and increased malignant degeneration (p<0.0001). This remained true after excluding all patients with diabetes and those on continued steroid administration. Five-year overall survival, progression-free survival and malignancy-free survival for persistent hyperglycemia versus relatively euglycemic cohorts were 43% versus 84%, 16% versus 46% and 46% versus 77%, respectively. Discussion: These findings may provide useful insight for increasing survival, decreasing tumor recurrence and decreasing malignant degeneration in patients undergoing surgery for low grade gliomas.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 55 条
  • [1] Altman DG, 1991, PRACTICAL STAT MED R, P336
  • [2] *AM ASS NEURL SURG, 1998, NEUROSURG FOCUS, V4, pE10
  • [3] Pretreatment factors predict overall survival for patients with low-grade glioma: A recursive partitioning analysis
    Bauman, G
    Lote, K
    Larson, D
    Stalpers, L
    Leighton, C
    Fisher, B
    Wara, W
    MacDonald, D
    Stitt, L
    Cairncross, JG
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (04): : 923 - 929
  • [4] BERGER MS, 1994, CANCER, V74, P1784, DOI 10.1002/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO
  • [5] 2-D
  • [6] Crooks V., 1991, J GERONTOL, V46, P139
  • [7] Oncogenic alterations of metabolism
    Dang, CV
    Semenza, GL
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (02) : 68 - 72
  • [8] Davis Faith S, 2007, Expert Rev Anticancer Ther, V7, pS3, DOI 10.1586/14737140.7.12s.S3
  • [9] A RANDOMIZED TRIAL OF RADIOTHERAPY VERSUS RADIOTHERAPY PLUS CCNU FOR INCOMPLETELY RESECTED LOW-GRADE GLIOMAS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    EYRE, HJ
    CROWLEY, JJ
    TOWNSEND, JJ
    ELTRINGHAM, JR
    MORANTZ, RA
    SCHULMAN, SF
    QUAGLIANA, JM
    ALSARRAF, M
    [J]. JOURNAL OF NEUROSURGERY, 1993, 78 (06) : 909 - 914
  • [10] THE ROLE OF POSTOPERATIVE IRRADIATION IN THE TREATMENT OF OLIGODENDROGLIOMA
    GANNETT, DE
    WISBECK, WM
    SILBERGELD, DL
    BERGER, MS
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (03): : 567 - 573